| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1332875 | Journal of Solid State Chemistry | 2006 | 8 Pages |
A series of pure silica MSU and carboxylic-modified MSU materials were prepared. The formation of mesoporous silica materials with terminal carboxylic groups on pore surface was performed by the acid-catalyzed hydrolysis of cyano to carboxylic. Then their potential applications in controlled drug delivery carriers were investigated. Drug famotidine was selected as a model molecule out of the consideration of the terminal amino groups in its molecule. The adsorption experiments show significant adsorption of famotidine on the carboxylic-modified MSU materials. And, the functionalization level of carboxylic groups has been found to be the key factor affecting the adsorption capacities of the modified MSU materials for famotidine. Subsequently, three kinds of release fluids, including simulated gastric medium, simulated intestinal medium, and simulated body fluid, were used to test the famotidine release rate from the carboxylic-modified MSU material. Obvious delayed effect has been observed for the famotidine release from the carboxylic-modified mesoporous silica material under the in vitro assays.
Graphical abstractCarboxylic-modified mesoporous silica MSU material was used as drug carrier, and the in vitro assays reveal the release of famotidine from the carboxylic-modified mesoporous silica material can be controlled to a high degree.Figure optionsDownload full-size imageDownload as PowerPoint slide
